AzTrials
AzTrials

MyelomeningocelePriumPsyNCT06796972

In Utero Surgery for Fetal Myelomeningocele: Decision-making Mechanisms and Psychological Impact of Prenatal Therapy

A study testing Semi-structured interviews with a psychologist in people with Myelomeningocele, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Myelomeningocele is a malformation of the spine and spinal cord, generally diagnosed prenatally, and responsible for a complex disability for the unborn child. In the event of continued pregnancy, in utero surgery can be performed to improve the prognosis of the children. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Myelomeningocele
What is being tested?
Semi-structured interviews with a psychologist
Could I receive a placebo?
No, everyone receives an active treatment
How many people
44 participants
Where
1 siteFrance
Study dates
23 Sep 2024to Mar 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Mothers and adult co-parents of the child with MMC operated in utero, having signed informed consent. If both members of the couple have agreed to participate, they will be received separately.
  • Mother who had fetal surgery for in utero repair of a fetal myelomeningocele by laparotomy and hysterotomy aged 18 years or older at the time of surgery, and whose child affected by the surgery is at least 6 months old
  • Speaking French
  • Not presenting a severe psychiatric disorder altering the relationship with reality
  • Patient affiliated to a social security system

Who cannot join

  • Patient under guardianship or curatorship, deprived of liberty or unable to sign informed consent to participate in the study
  • Patient under State Medical Aid

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Service de Médecine Foetale Hôpital Armand Trousseau

    Paris, Paris, 75012

    Lucie GILBAUD, MD, 00 33 6 31 82 32 71, lucie.guilbaud@aphp.fr

    Recruiting

Other trials in France

About this study

Myelomeningocele is a malformation of the spine and spinal cord, generally diagnosed prenatally, and responsible for a complex disability for the unborn child. In the event of continued pregnancy, in utero surgery can be performed to improve the prognosis of the children. This fetal therapy does not allow a cure and induces risks for the fetus, and for the mother, both during surgery and for her obstetric future.

Currently, few studies have focused on the factors influencing the choice to resort to in utero surgery and the experience of patients and co-parents before and after this intervention. No qualitative study on the subject has been published to date.

Read the detailed description

The study population corresponds to all couples who have chosen to continue the pregnancy in the face of a prenatal diagnosis of myelomeningocele in their fetus as well as to resort to in utero surgery to repair this malformation. In order to obtain the largest possible sample, the study will be offered to both couples who have had open surgery and those who have had fetoscopy.

This study aims to investigate, a posteriori, the experience of couples who have chosen fetal surgery to repair a myelomeningocele.

This is a study in clinical psychology, cross-sectional observational with an approach that will be mixed, qualitative and quantitative.

In practice, the only procedures added by the research will consist of:

  • an interview between the mother of the child operated on in utero and a psychologist researcher-student pair in Master 2 of psychology
  • an interview between the father of the child operated on in utero and a psychologist researcher-student pair in Master 2 of psychology
  • the completion of a decision scale by each of the parents The presence of the interview with a psychologist not planned as part of the care may lead to the modification of the usual care of the parents.
Being tested
Semi-structured interviews with a psychologist
Keywords
Psychology, fetal myelomeningocele, Parents
Medical subject headings
Meningomyelocele

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Semi-structured interviews with a psychologistOther

    Semi-directed interviews using an interview guide on different themes

Study groups in NCT06796972
Study groupRoleWhat they receive
Parents of children operated on in uteroOtherSemi-structured interviews with a psychologist
Receives: Other: Semi-structured interviews with a psychologist

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Studying the experience of couples who have chosen fetal surgery

    Semi-structured interviews with a psychologist

    Measured: up to 18 months

Secondary outcomes (2)
  1. Investigate the decision-making factors that contributed to the choice of prenatal surgery

    Semi-structured interviews with a psychologist

    Measured: Up to 18 months

  2. Evaluate the quality of the information that couples received regarding the three possibilities proposed when faced with a prenatal diagnosis of myelomeningocele

    Semi-structured interviews with a psychologist

    Measured: Up to 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2025
  2. Study start23 Sep 2024
  3. Primary completionMar 2026 (estimated)
  4. Study completionMar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
44 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06796972
Sponsor's protocol ID
APHP230369
Acronym
PriumPsy
Status last verified
Jan 2025
First submitted
22 Jan 2025
Last updated
28 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Semi-structured interviews with a psychologist in people with Myelomeningocele, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Lucie GILBAUD, MD (00 33 6 31 82 32 71, lucie.guilbaud@aphp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Studying the experience of couples who have chosen fetal surgery (time frame: up to 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in